supported by grants from the National Nature Science Foundation of China(30801111 and 30972923);Science&Technology Support Project of Sichuan Province(10SZ0166,14ZC1337 and 14ZC1335)
BACKGROUND: There is currently no effective medication to prevent stone recurrence after choledochoscopic lithotomy or to treat proliferative cholangitis(PC), which is the pathologic basis of hepatolithiasis. This ...
supported in part by a grant from the National Nature Science Foundation of China(30972923)
BACKGROUND: Acute cellular rejection(ACR) after liver transplantation(LT) is one of the most common problems faced by transplant recipients in spite of advances in immunosuppressive therapy. Recently, clinical tr...
supported by grants from the National Nature Science Foundation of China(30801111 and 30972923);Science&Technology Support Project of Sichuan Province(10SZ0166,14ZC1337 and 14ZC1335)
BACKGROUND: The high recurrence rate of hepatolithiasis and the high operative risk of right posterior, caudate or multiple lobe hepatectomy are the unsettled problems in hepatobiliary surgery. The present study was t...